Srikanya Laxmi
Epilepsy, a neurological disorder characterized by recurrent seizures, affects around 50 million people worldwide. Despite the availability of various Antiepileptic Drugs (AEDs), approximately one-third of patients have drug-resistant epilepsy, also known as refractory epilepsy. This subset of patients continues to experience seizures despite adequate trials of two or more AEDs. For these individuals, innovative therapeutic strategies are crucial. This article explores some of the latest therapeutic strategies showing promise in the management of drug-resistant epilepsy.
この記事をシェアする
English 
Spanish 
Chinese 
Russian 
German 
French 
Portuguese 
Hindi 